Viela Bio to Webcast First Quarter 2020 Financial Results and Program Highlights on May 13, 2020

Rhea-AI Summary

Viela Bio (Nasdaq: VIE) will host a webcast and conference call on May 13, 2020, at 5:00 p.m. ET to discuss its first quarter 2020 financial results and program highlights. The call will be accessible domestically at (877) 783-8848 or internationally at (631) 350-0960 using conference ID #: 3052446. The archived webcast will be available for replay approximately two hours after the event on the company's website. Viela Bio focuses on developing innovative treatments for autoimmune and severe inflammatory diseases.

Positive

• Upcoming conference call to discuss Q1 2020 financial results and program highlights may bolster investor confidence.

Negative

• None.

News Market Reaction – VIE

-6.96%

-6.96% Session move

In the trading session that priced this news, VIE declined 6.96%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GAITHERSBURG, Md., May 06, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory disease, today announced it will host a webcast and conference call on Wednesday, May 13, 2020 at 5:00 p.m. ET to discuss its first quarter 2020 financial results and program highlights.

The webcast will be accessible on the Events & Presentations page of the Company’s website. Individuals can participate in the conference call by dialing (877) 783-8848 (domestic) or (631) 350-0960 (international) and referring to conference ID #: 3052446. The archived webcast will be available for replay on the Viela Bio website approximately two hours after the event.

About Viela Bio

Viela Bio, headquartered in Gaithersburg, Maryland, is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases. For more information, please visit www.vielabio.com.

Source: Viela Bio

Contacts:

Investors:
Solebury Trout
Chad Rubin
646-378-2947
crubin@soleburytrout.com 

Media:
Solebury Trout
Amy Bonanno
914-450-0349
abonanno@soleburytrout.com

FAQ

What date is Viela Bio's conference call for Q1 2020 financial results?

The conference call is scheduled for May 13, 2020.

How can I access the Viela Bio conference call?

You can access the conference call by dialing (877) 783-8848 domestically or (631) 350-0960 internationally.

What is the conference ID for Viela Bio's upcoming call?

The conference ID for the call is 3052446.

Where can I find the archived webcast of Viela Bio's conference call?

The archived webcast will be available on Viela Bio's website approximately two hours after the event.